Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Chongqing Peg-Bio Biopharm Co., Ltd.
We are professional supplier of Intermediate of Semaglutide(P29).
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
1 Product Details
Chinese name:Recombinant double basic amino acid endopeptidase English name:Recombinant Kexin (rKex2)
CAS:37259-58-8 Brand:IMED
Place of Origin:Chongqing Storage Condition:-15°C
Purity:not less than 90% Product Category:Recombinant Protease
Grade:Pharmaceutical grade Alias:Double basic amino acid endopeptidase
Specification:1mg/branch,10mg/branch,0.5g/bottle,5g/bottle
Main Uses:rKex2 is widely used in biopharmaceutical recombinant proteins, peptide production and manufacturing, especially for insulin analogs (such as glucagon insulin) signal peptide, connecting peptide excision, can effectively avoid the risk of the B chain 22 position arginine miscut.
Completed DMF filing: 038568
2 Product Description
Dibasic amino acid endopeptidase (EC 3.4.21.61) is a serine protease that specifically recognizes and cleaves the carboxy-terminal peptide bond of Arg-Arg, Lys-Arg and other dibasic amino acids. The amino acid sequence of recombinant lysyl endopeptidase (rKex2) produced by Chongqing IMED is derived from Saccharomyces cerevisiae and prepared by recombinant expression in Saccharomyces cerevisiae. rKex2 has a cleavage pH range of 6.0-10.0, with an optimal pH of 9.0. rKex2 protease activity is not inhibited by conventional serine protease inhibitors, such as PMSF.
3 Quality Standard
Appearance | White or off-white lyophilized powder |
Electrophoretic purity | The purity of the main band is not less than 90% |
Relative molecular weight | 80kDa±10kDa |
Enzyme specific activity | Not less than 10.0U/mg |
Protein content | Not less than 50% |
Bacterial protein residue | Not more than 0.05% |
Exogenous DNA residue | Not more than 10ng/mg |
Bacterial endotoxin | Not higher than 100EU/mg |
Microbial limit | No more than 100cfu/g of total number of colonies |
4 Product Advantages
Recombinant expression preparation, the production process does not use animal source
materials, no risk of exogenous virus contamination;
3000L fermentation scale production line, with annual output of not less than 15kg; highly
consistent quality between batches as verified by multiple batch production;
The production workshop is operated according to GMP, and the production equipment,
environment and process control are implemented with reference to the Good
Manufacturing Practice (GMP);
Complementary rKex2 protease trace residue detection kit is available;
DMF filing has been completed: 038568;
Customized packaging specifications are available according to customers' requirements.